Pancreatic exocrine insufficiency following pancreatoduodenectomy: A prospective bi-center study

Pancreatology. 2022 Nov;22(7):1020-1027. doi: 10.1016/j.pan.2022.08.002. Epub 2022 Aug 5.

Abstract

Background/objectives: Pancreatic exocrine insufficiency (PEI) is a common complication following pancreatoduodenectomy (PD) leading to malnutrition. The course of PEI and related symptoms and vitamin deficiencies is unknown. This study aimed to assess the (long-term) incidence of PEI and vitamin deficiencies after PD.

Methods: A bi-centre prospective observational cohort study was performed, including patients who underwent PD for mainly pancreatic and periampullary (pre)malignancies (2014-2018). Two cohorts were formed to evaluate short and long-term results. Patients were followed for 18 months and clinical symptoms were evaluated by questionnaire. PEI was based on faecal elastase-1 (FE-1) levels and/or clinical symptoms.

Results: In total, 95 patients were included. After three months, all but three patients had developed PEI and 27/29 (93%) patients of whom stool samples were available showed abnormal FE-1 levels, which did not improve during follow-up. After six months, all patients had developed PEI. During follow-up, symptoms resolved in 35%-70% of patients. Vitamin D and K deficiencies were observed in 48%-79% of patients, depending on the moment of follow-up; 0%-50% of the patients with deficiencies received vitamin supplementation.

Discussion: This prospective study found a high incidence of PEI after PD with persisting symptoms in one-to two thirds of all patients. Limited attention was paid to vitamin deficiencies. Improved screening and treatment strategies for PEI and vitamins need to be designed.

Keywords: Pancreatic exocrine insufficiency; pancreatic cancer; pancreatic enzyme replacement therapy; pancreatic surgery.

Publication types

  • Observational Study

MeSH terms

  • Exocrine Pancreatic Insufficiency* / diagnosis
  • Exocrine Pancreatic Insufficiency* / epidemiology
  • Exocrine Pancreatic Insufficiency* / etiology
  • Humans
  • Pancreas
  • Pancreaticoduodenectomy* / adverse effects
  • Prospective Studies
  • Vitamin A

Substances

  • Vitamin A